packageSparsentan

sparsentan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sparsentan is used to treat IgA glomerulonephritis, a kidney disease. It is approved and authorised in the European Union, though it remains under investigation for other uses and carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q27088845 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sparsentan
ATC codes:C09XX01
DrugBank:DB12548
PubChem CID:10257882
Wikidata:Q27088845
formula:C32H40N4O5S
molar mass:592.755 g/mol (PubChem CID 10257882)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown